Abstract:4158 G-protein-coupled receptors (GPCRs) represent the largest protein family in the human genome, and are involved in many cellular processes such as migration, proliferation, and invasion. GPCRs induce biological effects through the association of their cytoplasmic domains with trimeric G proteins that activate multiple signaling cascades, leading to the activation of various transcription factors including NF-κB. NF-κB is a family of transcription factors that play a pivotal role in regulating gene expression of many cytokines and survival factors. However, the molecular mechanism by which GPCRs induce NF-κB activation has not been fully characterized. Here we demonstrate that CARMA3 (Caspase recruitment domain and membrane associated guanylate kinase domain-containing protein 3), a scaffold molecule, is essential for GPCR-induced NF-κB activation. Using a gene-targeting approach, we generated CARMA3-deficient mice. We found that CARMA3-deficient mice exhibit a neural tube closure defect with incomplete penetrance, similar to that of a CARMA3-binding partner, Bcl10 (B-cell lymphoma protein 10). Using CARMA3-deficient cells, we show that the GPCR-ligands LPA (lysophosphatidic acid), ET-1 (endothelin-1), and 5-HT (serotonin) all signal through CARMA3 to activate NF-κB. Furthermore, 12-phorbol-myristate-13-acetate (PMA) and ionomycin (Iono.), two synthetic protein kinase C (PKC) agonists, also fail to activate NF-κB in CARMA3-deficient cells. Finally, our results indicate that this NF-κB activation defect is not due to an absence of phosphorylation of the inhibitor of NF-κB kinases (IKK) α and β. Instead, this defect is likely due deficient ubiquitination of the NF-κB-essential modulator (NEMO). Thus, we have provided the first genetic evidence that CARMA3 plays an essential role downstream of GPCRs and PKC to regulate NEMO ubiquitination, ultimately leading to NF-κB activation.

CARMA3 is Crucial for EGFR-Induced Activation of NF-κB and Tumor Progression

CARMA3 Deficiency Abrogates G-protein-coupled Receptor Induced NF-κB Activation

Carma3 Deficiency Abrogates G Protein-Coupled Receptor-Induced Nf-Kappa B Activation

Analysis of Epidermal Growth Factor-Induced NF-κB Signaling.

CARMA3: Scaffold Protein Involved in NF-κB Signaling

CARMA3: A potential therapeutic target in non-cancer diseases

A Requirement for CARMA1 in TCR-induced NF-κB Activation

CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion

Epithelial Growth Factor Receptor-Activated Nuclear Factor Κb Signaling and Its Role in Epithelial Growth Factor Receptor-Associated Tumors.

TMEM43/LUMA is a Key Signaling Component Mediating EGFR-induced NF-κB Activation and Tumor Progression

NF-κB Signaling Pathways Regulated by CARMA Family of Scaffold Proteins

CD3/CD28 Costimulation-Induced NF-κB Activation is Mediated by Recruitment of Protein Kinase C-θ, Bcl10, and IκB Kinase Β to the Immunological Synapse Through CARMA1

CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate

CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1.

CARMA1-mediated NF-kappaB and JNK Activation in Lymphocytes.

CARMA1 Coiled-coil Domain is Involved in the Oligomerization and Subcellular Localization of CARMA1 and is Required for T Cell Receptor-induced NF-κB Activation*

Phosphorylation of Carma1 Plays A Critical Role in T Cell Receptor-Mediated Nf-Kappa B Activation

CARMA3 deficiency aggravates angiotensin II-induced abdominal aortic aneurysms development interacting between endoplasmic reticulum and mitochondria

The CBM Complex Underwrites NF-kappaB Activation to Promote HER2-associated Tumor Malignancy

Potential Role of Carma1 in Cd40-Induced Splenic B Cell Proliferation and Marginal Zone B Cell Maturation

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A